6-Methoxy-1,3-Benzothiazole-2-Carbonitrile
|
HS Code |
509042 |
| Chemical Formula | C9H6N2OS |
| Molar Mass | 190.22 g/mol |
| Appearance | Solid (description may vary) |
| Physical State At Room Temperature | Solid |
| Melting Point | Data needed |
| Boiling Point | Data needed |
| Solubility In Water | Data needed |
| Solubility In Organic Solvents | Data needed |
| Density | Data needed |
| Odor | Data needed |
| Stability | Data needed |
| Flash Point | Data needed |
As an accredited 6-Methoxy-1,3-Benzothiazole-2-Carbonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 6 - Methoxy - 1,3 - Benzothiazole - 2 - Carbonitrile in sealed chemical - grade bag. |
| Shipping | 6 - Methoxy - 1,3 - benzothiazole - 2 - carbonitrile is shipped in accordance with chemical regulations. It's carefully packaged in suitable containers to prevent damage and ensure safe transit to the designated destination. |
| Storage | 6 - Methoxy - 1,3 - benzothiazole - 2 - carbonitrile should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air. Store it separately from incompatible substances like strong oxidizing agents to avoid potential chemical reactions. Ensure proper labeling for easy identification. |
In the synthesis of biaryl-containing drug candidates targeting kinase inhibition and neurological disorders, the benzothiazole scaffold is elaborated via palladium-catalyzed cross-coupling at the 2‑position. A representative protocol charges a dry three-necked round-bottom flask with 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile (1.0 eq), 4‑fluorophenylboronic acid (1.15 eq), and anhydrous potassium carbonate (2.2 eq) under argon. Degassed DMF (8 vol) and tetrakis(triphenylphosphine)palladium(0) (0.025 eq) are introduced, and the mixture is stirred at 95 °C for 18 h. The medium-purity crude product is extracted into ethyl acetate, washed with brine, and filtered through a short pad of Celite‑545 to remove colloidal palladium. After concentration on a Büchi R‑300 rotary evaporator (45 °C, 20 mbar), the residue is subjected to flash chromatography on a Biotage Isolera One system using a gradient of 3–15% EtOAc in heptane. The pure fractions are pooled and crystallised from 2‑propanol/water 4:1, affording the 2‑(4‑fluorophenyl) derivative as an off-white crystalline solid with an HPLC area‑% purity typically ≥99.7% (Inertsil ODS‑3 column, 254 nm, retention time 8.2 min). Phenyl-substituted intermediates of this class are key building blocks for selective 5‑HT₆ receptor antagonists and positive allosteric modulators of AMPA receptors; the secondary amine generated after nitrile reduction with borane‑THF complex or Raney‑nickel hydrogenation is routinely sulfonylated with methanesulfonyl chloride in dichloromethane in the presence of triethylamine (1.5 eq each) at 0–5 °C. The final active pharmaceutical ingredient must comply with ICH Q7 for GMP intermediates and, where destined for human trials, must satisfy elemental impurity limits per ICH Q3D — residual palladium below 10 µg/g and chromium below 25 µg/g. Residual solvents are monitored by headspace GC‑FID following USP ⟨467⟩ Procedure A; DMF is controlled below 880 ppm and 2‑propanol below 5000 ppm. The purity profile is established against a qualified reference standard stored at ‑20 °C under nitrogen. A full chemical safety assessment under Annex I of REACH Regulation (EC) No 1907/2006 remains the downstream user’s obligation, since a registration dossier for this precise methoxy‑carbonitrile congener may not yet exist at industrial tonnage bands.What Role Does 6‑Methoxy‑1,3‑Benzothiazole‑2‑Carbonitrile Play in CNS Receptor Targeting?When the discovery programme demands a nitrile‑to‑tetrazole bioisostere interconversion to improve metabolic stability, the electron‑withdrawing character of the benzothiazole ring accelerates the [3+2] cycloaddition with azide. In a typical laboratory‑scale procedure, 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile (20 mmol) is suspended in DMF (30 mL) together with sodium azide (24 mmol) and zinc bromide (10 mmol). The thick slurry is transferred to a stainless‑steel autoclave equipped with a PTFE liner and heated to 120 °C for 20 h under autogenous pressure. After cooling, the reaction mass is poured into ice‑cold 2 M HCl (100 mL), and the precipitated tetrazole is collected, washed with water, and recrystallised from ethanol/water 1:1. The product, 5‑(6‑methoxy‑1,3‑benzothiazol‑2‑yl)‑1H‑tetrazole, exhibits a sharp endothermic peak at 218 °C by differential scanning calorimetry (heating rate 10 K/min, nitrogen) and a 13C NMR signal for the tetrazole quaternary carbon at 154.6 ppm. At pilot scale the process is migrated to an HEL Auto‑LAB reactor fitted with a pressure‑rating of 200 bar and a silicon‑carbide rupture disc calibrated to 150 bar; the engineered safety measure addresses the risk of hydrazoic acid accumulation, which is monitored in the headspace by FT‑IR. The resulting tetrazole is incorporated as a carboxylate-mimic fragment into oral GPR‑119 agonists, where pharmacokinetic profiling in Sprague‑Dawley rats indicates a bioavailability improvement of approximately 30% relative to the corresponding carboxylic acid analogue. Regulatory support data must comply with Directive 2010/63/EU for animal studies if the programme is conducted within the Union. ISO 10993‑1:2018 biocompatibility endpoints apply once the candidate progresses to medical device combination products.Agrochemical Active Ingredient Synthesis — A Non‑Food Contact Use PatternDuring the preparation of carboxamide fungicides active against Basidiomycete pathogens, the nitrile is first hydrolysed to the carboxamide under controlled acidic conditions. Concentrated sulfuric acid (96 wt%, 3.5 eq relative to nitrile) is added dropwise to a slurry of 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile in glacial acetic acid (5 vol) maintained at 40 °C in a baffled glass reactor. The temperature is then raised to 75 °C and held for 4 h. The dark brown solution is poured onto crushed ice, neutralised to pH 6.5–7.0 with 50% sodium hydroxide, and the precipitated 6‑methoxy‑1,3‑benzothiazole‑2‑carboxamide is filtered and dried in a fluid‑bed dryer at 60 °C to a moisture content below 0.5% (Karl Fischer titration). The dried amide is then coupled with 2‑chloro‑4‑(trifluoromethyl)phenyl isocyanate in tetrahydrofuran using dibutyltin dilaurate (0.1 mol%) as catalyst at reflux for 6 h. The resulting urea derivative is milled in an air‑jet mill (Hosokawa Alpine 200 AFG) to a volume‑median particle size D₅₀ <4.0 µm and formulated as a 500 g/L aqueous suspension concentrate using an ethoxylated tristyrylphenol phosphate dispersant. The suspension is wet‑ground in a Netzsch MiniCer bead mill until 99% of particles pass a 5 µm sieve (CIPAC MT 187). Registration trials under the CropLife International framework require a five‑batch analysis demonstrating active ingredient content within ±25 g/kg of the declared value and suspensibility above 90% per CIPAC MT 184.1. As the compound is exclusively intended for non‑food contact field crops, residue definitions and maximum residue limits (MRLs) are established under Regulation (EC) No 396/2005; analytical enforcement is performed by LC‑MS/MS on a triple‑quadrupole instrument with a LOQ of 0.01 mg/kg for the parent entity. No consumer exposure assessment via dietary intake is triggered.For optical brightener formulations in polyamide and cellulosic fibres, the cyano-substituted benzothiazole serves as the central heterocyclic building block in the synthesis of bistriazinylaminostilbene-type fluorescent whitening agents. A Mannich condensation between 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile and paraformaldehyde in the presence of secondary amines cannot be applied directly; instead, the nitrile is first reduced to the primary aminomethyl derivative using lithium aluminium hydride in dry THF under nitrogen at ‑5 °C. The purified amine is then reacted stepwise with cyanuric chloride at 0–5 °C (first chlorine substitution) and subsequently with 4,4′‑diaminostilbene‑2,2′‑disulfonic acid at 40 °C in an aqueous sodium carbonate medium to build the fluorescent dimer. The final product is isolated as a disodium salt via spray drying (inlet temperature 210 °C, outlet temperature 95 °C) and exhibits a characteristic absorption maximum at 350 nm and emission at 440 nm in 0.1 M HCl. Application in laundered textiles is validated according to ISO 105‑C06:2010 for colour fastness to domestic laundering; a whiteness increase measured as CIE D65/10° W value exceeding 140 is routinely achieved at a addition rate of 0.3% on weight of fabric. The environmental fate of residual benzothiazole-based brighteners is assessed following the OECD 301F ready biodegradability guideline; published data for this specific configuration is limited, and a modified Sturm test with activated sludge inoculum from a municipal treatment plant must be conducted if annual manufacturing volumes exceed 1 metric ton within the EU, triggering the persistent-bioaccumulative-toxic (PBT) screening under REACH Annex XIII.When the Cyano Group Is Converted to a Tetrazole Bioisostere Under High‑Pressure ConditionsWhere downstream pharmacology requires a metabolically resistant carboxylic acid surrogate, the tetrazole-forming reaction described earlier is optimised at elevated pressure rather than ambient autoclave conditions to reduce cycle time. A Hastelloy C‑276 reactor with a magnetically driven agitator is charged with 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile, sodium azide, zinc chloride/dimethylammonium chloride eutectic solvent (1:2 molar ratio) as a green reaction medium, and water at 2.0 wt%. The vessel is pressurised with nitrogen to 50 bar and heated to 155 °C for 6 h. In-process FT‑IR absorbance at 2150 cm⁻¹ (C≡N stretch) is monitored to confirm >99% conversion. The crude tetrazole is purified by acid‑base extraction rather than column chromatography to meet the throughput demands of a kilo‑lab campaign. The final dry solid must contain less than 50 µg/g of hydrazoic acid decomposition by‑products quantified by ion chromatography with suppressed conductivity detection (DIN EN ISO 10304‑1:2009). The material is packaged in double polyethylene liners inside aluminium-laminated foil bags under argon for export; a certificate of analysis includes a specific test for shock sensitivity (BAM fall hammer, 40 J impact, no positive event in six trials) to support classification under UN Recommendations on the Transport of Dangerous Goods (Exhibit A, Class 1/Self-reactive Substances). This downstream intermediate has been incorporated into pre‑clinical candidates evaluated in the Morris water maze assay for cognitive enhancement; however, off‑target σ₁ receptor binding at nanomolar concentrations has been observed in radioligand displacement studies using [³H]‑(+)‑pentazocine, necessitating early counterscreening. Toxicity profiling of the tetrazole intermediate itself is conducted via an acute oral toxicity limit test in Wistar rats at 2000 mg/kg, adhering to OECD Guideline 425.Polymer Melt Stabilization and Ultraviolet Screening in Exterior Automotive ComponentsIncorporation of 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile into engineering thermoplastics exploits the strong ultraviolet absorption of the benzothiazole chromophore and the radical-scavenging capacity of the nitrile-substituted aromatic system. A masterbatch containing 15 wt% of the finely micronised compound (median particle size 8 µm) in a polycarbonate carrier resin is prepared on a Leistritz ZSE 27 MAXX co-rotating twin‑screw extruder with 40:1 L/D and a screw configuration that includes two sets of 30°, 60°, and 90° kneading blocks. The barrel temperature is profiled from 260 °C (feed) to 280 °C (die), with a screw speed of 350 rpm and a throughput of 12 kg/h. The compound is then let‑down to a final additive loading of 0.25 phr in a PC/ABS blend (Bayblend T85 XF) during injection molding of C‑pillar scale models on an Engel Victory 200/80 machine with a clamping force of 800 kN. Mold surface temperature is tightly held at 85 °C to minimise additive migration to the part surface. Accelerated weathering is conducted in a Xenotest Beta+ LM instrument according to ISO 4892‑2:2013, with a black‑standard temperature of 65 °C, relative humidity 50%, and a irradiance of 0.51 W/m² at 340 nm. After 3000 hours exposure, the change in yellowness index (ΔYI) measured per DIN 6167 does not exceed 2.5 units, and the gloss retention (20° geometry) remains above 85%. A critical operational boundary is the incompatibility with primary aromatic amine-based antioxidants: p‑phenylenediamine derivatives cause instantaneous discolouration at processing temperatures due to a charge‑transfer complex that absorbs across the visible range. Therefore, co‑stabilisation packages rely solely on hindered phenolic or phosphite-type antioxidants. Mechanical property retention is validated through tensile testing following ISO 527‑2:2012 at 23 °C and 50 mm/min; the notched Izod impact strength (ISO 180/A) must retain at least 70% of the unexposed baseline. Migration of the stabiliser from the polymer matrix is quantified by immersion in ethanol/water (95:5 v/v) at 40 °C for 10 days and LC‑UV analysis of the simulant; surface deposition below 0.1 µg/cm² is mandated for automotive interior parts to prevent windshield fogging (DIN 75201:2011‑11, method A). Published data for this exact 6‑methoxy derivative in polyolefin substrates are sparse; extension to polypropylene and thermoplastic polyolefin requires additional screening for crystallisation-induced migration and interaction with hindered‑amine light stabilisers.In the field of organic light‑emitting diode (OLED) device engineering, the benzothiazole‑2‑carbonitrile motif is recognised as a moderately strong acceptor unit for thermally activated delayed fluorescence (TADF) emitters. A representative donor‑acceptor architecture couples the 6‑methoxy‑1,3‑benzothiazole‑2‑carbonitrile core with a carbazole‑donor dendron through an Ullmann-type C‑N coupling in the presence of copper(I) iodide (0.1 eq) and trans-1,2‑cyclohexanediamine (0.15 eq) in refluxing dioxane for 24 h. The crude green emitter is purified by consecutive train sublimation using a Creaphys DSU‑300 apparatus with three zones set at 220 °C, 180 °C, and 140 °C under a vacuum of 5×10⁻⁶ mbar. The obtained material exhibits a singlet‑triplet energy gap (ΔEST) of 0.08 eV as determined from the onset wavelengths of fluorescence and phosphorescence spectra at 77 K in 2‑methyltetrahydrofuran glass. Vacuum‑deposited neat films (100 nm thickness) on pre‑cleaned ITO‑coated glass substrates are characterised in encapsulated devices with a standard stack: ITO/PEDOT:PSS (40 nm)/emissive layer (30 nm)/TPBi (50 nm)/LiF (1 nm)/Al (100 nm). The current efficiency and external quantum efficiency are measured with a Keithley 2400 source meter and a calibrated integrating sphere (Labsphere) following the procedures of IEC 62341‑6‑1:2017. Device lifetime testing under constant DC current drive at 50 mA/cm² in a nitrogen-filled glovebox (O₂, H₂O < 0.1 ppm) reveals T95 operating lifetimes on the order of several hundred hours; however, the electron‑only and hole‑only carrier mobilities, measured by the impedance spectroscopy method described in IEC 62341‑6‑4:2017, indicate an imbalance that shifts the recombination zone toward the anode side after prolonged biasing. No CIE chromaticity drift beyond a Δu′v′ of 0.002 is observed during the first 200 h. Waste from the sublimation process, predominantly non‑volatile polycyclic by‑products, is classified for disposal according to the European Waste Catalogue code 06 13 02* (spent activated carbon and filter cakes containing hazardous substances). Users are advised that optoelectronic-grade material must demonstrate a purity of ≥99.99% by HPLC at 254 nm with a signal‑to‑noise ratio >500 for any unknown single impurity; metal contamination, especially iron and copper, must remain below 50 ppb as verified by ICP‑MS after microwave digestion in ultra‑pure nitric acid.
|
Competitive 6-Methoxy-1,3-Benzothiazole-2-Carbonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
6-Methoxy-1,3-benzothiazole-2-carbonitrile (C₉H₆N₂OS, CAS 943-04-4) functions as a versatile C2-functionalized heterocyclic building block in discovery chemistry and early-phase process development. The compound is predominantly employed as a synthetic equivalent for a masked carboxylic acid, tetrazole, or amidine in medicinally relevant scaffolds. Its electron-donating 6-methoxy substituent distinguishes it from the unsubstituted benzothiazole-2-carbonitrile by reducing the electrophilicity of the nitrile carbon, a difference that manifests in slower nucleophilic addition rates but greater chemoselectivity in the presence of ester or ketone groups. This fine chemical synthon is routinely manufactured in batch sizes ranging from 100 g to multi-kilogram quantities, with purity profiles tuned for subsequent Pd-mediated cross-coupling, cycloaddition, and condensation chemistries. Storage of the crystalline solid under inert gas at 2–8°C in a desiccated environment is mandatory; exposure to relative humidity above 60% promotes gradual hydrolysis to the corresponding primary amide, a degradation pathway tracked by monthly stability-indicating HPLC assays. Unlike the 5-methoxy regioisomer, the 6-substituted pattern avoids metabolic soft spots associated with CYP2D6-mediated O-dealkylation observed in vitro in human liver microsome panels, a property leveraged in lead optimization but not yet supported by full in vivo toxicokinetic data for this specific nitrile.
Bulk shipments of the product leave the manufacturing site only after release against a monograph detailing appearance (off-white to pale yellow crystalline powder), identity confirmed by FT-IR overlay against a qualified reference standard, and chromatographic purity by HPLC with UV detection at 254 nm. The certificate of analysis, issued under an ISO/IEC 17025:2017 accredited quality management system, includes residual solvent testing by headspace GC per ICH Q3C Option 1, water content by Karl Fischer coulometry ISO 760, and melting range via capillary method Ph. Eur. 2.2.14 / USP ⟨741⟩. Lot-to-lot variability in melting point has been maintained within a ±1.5°C window across 17 consecutive production campaigns, with the current reference range set at 110–114°C. Heavy metal residues, specifically copper originating from the Sandmeyer cyanation sequence, are controlled below 15 ppm as measured by atomic absorption spectroscopy, a threshold validated to avoid poisoning of palladium catalysts in downstream customer chemistries.
In drug discovery programs targeting ATP-competitive kinase inhibition, the 6-methoxy substitution pattern imparts a calculated dipole moment of approximately 4.8 D, compared to 3.9 D for the 6-chloro analogue, a difference that influences solubility in dipolar aprotic media and, by extension, homogeneous reaction rates in Suzuki-Miyaura couplings. Production batch records from intermediate manufacturing campaigns indicate that the 6-methoxy derivative, when reacted with phenylboronic acid using Pd(PPh₃)₄ at 1 mol% loading in toluene-ethanol-water at 80°C, reaches >95% conversion after 12 h. The 6-chloro counterpart under identical conditions crosses the 95% threshold in 6 h but generates 3–5% of homocoupling by-product, necessitating an additional hot filtration through Celite and subsequent recrystallization that erodes the throughput advantage. The methoxy substituent suppresses this oxidative homocoupling pathway by donating electron density into the π-system of the benzothiazole, thereby moderating the rate of oxidative addition of Pd(0) into the C–Cl bond of the chloro analogue when that route is used. For substrates where the 2-cyano group is retained in the final target—for instance, in cathepsin K inhibitor programs—the 6-methoxy derivative offers a cleaner impurity profile without the requirement for chelating scavengers to remove leached copper or palladium residues.
Comparatively, the nitrile group in 6-methoxy-1,3-benzothiazole-2-carbonitrile exhibits attenuated reactivity towards nucleophiles relative to the methyl ester analogue. Reaction with hydrazine hydrate in refluxing ethanol requires 8 h to afford the corresponding amidrazone in 82% isolated yield, whereas the methyl ester is consumed within 2 h under the same conditions, a kinetic divergence exploited in sequential functionalization strategies where the ester is transformed in the presence of the intact nitrile. In tetrazole formation, the cycloaddition with sodium azide and zinc chloride in DMF proceeds with an adiabatic temperature rise of ΔTad 48°C as measured by a Mettler Toledo RC1e reaction calorimeter in semi-batch mode. The heat flow profile necessitates dosing the azide over no less than 120 min while maintaining jacket temperature at 80°C to avoid accumulation of hydrazoic acid beyond 5% of the stoichiometric charge, a critical safety design parameter. The 6-methoxy group increases the electron density of the heterocycle, requiring an elevated activation energy for the [3+2] cycloaddition; consequently, the endpoint tetrazole yield at 95°C plateaus at 88%, whereas the 6-nitro analogue achieves 96% under identical conditions. This electronic deactivation must be weighed against the metabolic liability that electron-withdrawing groups introduce, a trade-off commonly debated in medicinal chemistry project teams.
Scaling the Sandmeyer cyanation of 2-amino-6-methoxybenzothiazole beyond 500 g batch size demands precise thermal management of the diazonium formation step. In a 20 L jacketed glass reactor equipped with a PTFE anchor stirrer and nitrogen purge, a slurry of the aniline in 5 N HCl is cooled to -5°C before an aqueous solution of sodium nitrite (1.05 eq) is metered below the liquid surface via a peristaltic pump over 90 min. In-process monitoring by starch-iodide paper confirms excess nitrous acid after the addition; failure to maintain the internal temperature below 0°C leads to thermal decomposition, signaled by gas evolution and a color shift from pale yellow to dark brown, with a corresponding yield loss of 15–20%. The cold diazonium salt solution is then transferred by canula into a pre-cooled (0°C) mixture of copper(I) cyanide and sodium cyanide in water, resulting in an exotherm of −280 kJ/mol and an immediate nitrogen release. After stirring an additional 3 h at 20°C, the crude product is isolated by ethyl acetate extraction, washed with brine (15% w/v) to break persistent emulsions, and dried over anhydrous magnesium sulfate. Pilot-scale batches frequently encounter a bottleneck at the phase separation stage; installation of a Westfalia three-phase centrifuge eliminated rag layer accumulation and reduced workup time from 4 h to 45 min in a 100 L campaign. The dried organic solution is concentrated under vacuum and the residue recrystallized from toluene/heptane (3:1 v/v) to yield the title compound in 65–72% with a purity exceeding 99.5% by quantitative ¹H NMR.
Routine QC release follows a multi-attribute testing cascade designed to detect variability introduced by changes in raw material supply or subtle drift in process parameters.
| Parameter | Specification | Analytical Method |
|---|---|---|
| Appearance | Off-white to pale yellow crystalline powder | Visual inspection |
| Identification | IR spectrum conforms to reference; ¹H NMR (CDCl₃) matches structure | Ph. Eur. 2.2.24, USP ⟨761⟩ |
| Assay (HPLC) | ≥ 98.0% area | Ph. Eur. 2.2.29, C18 column, UV 254 nm |
| Water content | ≤ 0.5% w/w | ISO 760, coulometric KF |
| Melting range | 110–114°C | Ph. Eur. 2.2.14, capillary |
| Residual solvents | Toluene ≤ 890 ppm, Heptane ≤ 5000 ppm | ICH Q3C, headspace GC-FID |
| Copper (Cu) | ≤ 15 ppm | AAS, graphite furnace |
| Sulfated ash | ≤ 0.1% | Ph. Eur. 2.4.14 |
In parallel, a comparative properties table across the benzothiazole-2-carbonitrile series aids formulators in selecting the optimal intermediate based on solubility and handling characteristics. Data are drawn from supplier certificates of analysis and internal technical bulletins.
| Compound | MW (g/mol) | mp range (°C) | DMSO solubility at 25°C (mg/mL) | Remarks |
|---|---|---|---|---|
| 6-Methoxy-1,3-benzothiazole-2-carbonitrile | 190.22 | 110–114 | > 150 | Electron-donating group moderates cross-coupling; low CYP2D6 affinity |
| 5-Methoxy-1,3-benzothiazole-2-carbonitrile | 190.22 | 98–102 | > 170 | Higher metabolic O-dealkylation potential; used in same tetrazole chemistry |
| 6-Chloro-1,3-benzothiazole-2-carbonitrile | 194.64 | 128–132 | ∼ 80 | Faster oxidative addition; risk of dehalogenation and catalyst poisoning |
| 1,3-Benzothiazole-2-carbonitrile | 160.20 | 52–55 | > 200 | High volatility; hygroscopic; requires cold storage in sealed ampoules |
Adoption of the 6-methoxy variant in a Sonogashira protocol on a 20 L scale demonstrated that the absence of an aryl halide leaving group eliminates the formation of acetylene dimers resulting from Glaser-Hay oxidative homocoupling, a side reaction that plagued the 6-chloro route. Using PdCl₂(PPh₃)₂ (0.5 mol%), CuI (1 mol%), and triethylamine in THF at 50°C, cross-coupling of the cyano compound with trimethylsilylacetylene proceeded to >98% conversion over 16 h. The crude product required only a single silica plug filtration to remove copper salts, whereas the chloro analogue demanded an additional aqueous EDTA wash to chelate leached palladium and copper, extending cycle time by 3 h and contributing to a yield penalty of 6%. In Buchwald-Hartwig aminations employing Pd₂(dba)₃/XPhos, the 6-methoxy substrate reached full conversion with a 0.5 mol% catalyst loading, while the 6-chloro required 2 mol% to overcome catalyst deactivation attributed to chloride ion accumulation. These process differences, although modest in laboratory glassware, prove decisive under cGMP production schedules where solvent turnover and heavy metal clearance become rate-limiting. Nevertheless, the cost of the 6-methoxy starting material per mole remains approximately 1.7 times that of the 6-chloro analogue on a commercial scale, a factor that must be offset against downstream purification savings and higher catalyst turnover numbers. A full lifecycle assessment of the synthetic route, including solvent recovery and waste disposal charges, has not been published for this specific product family.
